PLC and PI3K/Akt/mTOR signalling in disease and cancer

MY Follo, L Manzoli, A Poli, JA McCubrey… - Advances in biological …, 2015 - Elsevier
Cancer cell metabolism is deregulated, and signalling pathways can be involved. For
instance, PI3K/Akt/mTOR is associated with normal proliferation and differentiation, and its …
被引用次数：149 相关文章

[引用][C] PLC and PI3K/Akt/mTOR signalling in disease and cancer

MY Follo, L Manzoli, A Poli, JA McCubrey… - Advances in Biological …, 2015 - cir.nii.ac.jp
PLC and PI3K/Akt/mTOR signalling in disease and cancer | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

PLC and PI3K/Akt/mTOR signalling in disease and cancer.

MY Follo, L Manzoli, A Poli, JA McCubrey… - Advances in Biological …, 2014 - europepmc.org
Cancer cell metabolism is deregulated, and signalling pathways can be involved. For
instance, PI3K/Akt/mTOR is associated with normal proliferation and differentiation, and its …

PLC and PI3K/Akt/mTOR signalling in disease and cancer

MY Follo, L Manzoli, A Poli, JA Mccubrey… - ADVANCES IN …, 2015 - cris.unibo.it
Cancer cell metabolism is deregulated, and signalling pathways can be involved. For
instance, PI3K/Akt/mTOR is associated with normal proliferation and differentiation, and its …

PLC and PI3K/Akt/mTOR signalling in disease and cancer

MY Follo, L Manzoli, A Poli… - Advances in …, 2015 - pubmed.ncbi.nlm.nih.gov
Cancer cell metabolism is deregulated, and signalling pathways can be involved. For
instance, PI3K/Akt/mTOR is associated with normal proliferation and differentiation, and its …

PLC and PI3K/Akt/mTOR signalling in disease and cancer

MY Follo, L Manzoli, A Poli, JA McCubrey… - Advances in Biological …, 2015 - infona.pl
Cancer cell metabolism is deregulated, and signalling pathways can be involved. For
instance, PI3K/Akt/mTOR is associated with normal proliferation and differentiation, and its …